U.S. Interventional Cardiology Devices Market Size & Outlook
- MedTech
- Cardiovascular Devices
- Interventional Cardiology Devices Market Outlook
- Cardiovascular Devices
Global Market
Related Markets
Ask a question about the interventional cardiology devices market
U.S. interventional cardiology devices market highlights
- The U.S. interventional cardiology devices market generated a revenue of USD 4,656.8 million in 2025 and is expected to reach USD 7,863.8 million by 2033.
- The U.S. market is expected to grow at a CAGR of 6.8% from 2026 to 2033.
- In terms of segment, coronary stents was the largest revenue generating products in 2025.
- Accessory Devices is the most lucrative products segment registering the fastest growth during the forecast period.
Interventional cardiology devices market data book summary
| Market revenue in 2025 | USD 4,656.8 million |
| Market revenue in 2033 | USD 7,863.8 million |
| Growth rate | 6.8% (CAGR from 2026 to 2033) |
| Largest segment | Coronary stents |
| Fastest growing segment | Accessory Devices |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Coronary Stents, PTCA Balloon Catheters, Intravascular Imaging Catheters and Pressure Guidewires, Accessory Devices |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
Other key industry trends
- In terms of revenue, U.S. accounted for 41.3% of the global interventional cardiology devices market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. interventional cardiology devices market is projected to lead the regional market in terms of revenue in 2033.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 181.9 million by 2033.
In the U.S., heart diseases and stroke pose a significant health burden, affecting approximately 795,000 individuals annually. The frequency is overwhelming, with individuals experiencing a stroke every 40 seconds, and every 4 minutes, a person dies due to stroke, totaling more than 140,000 deaths each year.
In another development, in February 2022, Boston Scientific Corporation announced the acquisition of Baylis Medical Company Inc., a company that offers sheaths, dilators, guidewires, and advanced transseptal access solutions used to support left heart catheter-based procedures.
Reimbursement scenarios and costs for cardiology devices in the U.S. are primarily determined by various public and private payers, including Medicare, Medicaid, & private insurance companies. A few manufacturers also provide guides for payment, such as Boston Scientific, which annually publishes clear instructions on procedural billing & reimbursement payer policies for inpatient, outpatient, office, and ASC settings.
No credit card required*
Publish Date: Apr 15, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Interventional Cardiology Devices Market Scope
Interventional Cardiology Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Boston Scientific Corp | View profile | 48,000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | www.bostonscientific.com |
| Teleflex Inc | View profile | 14,500 | 550 East Swedesford Road, Suite 400, Wayne, PA, United States, 19087 | www.teleflex.com |
| Terumo Corp | View profile | 30,207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | www.terumo.com |
| Cardinal Health Inc | View profile | 48,000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | www.cardinalhealth.com |
| B. Braun | View profile | 10001+ | Chapeltown, Sheffield, United Kingdom, Europe | www.bbraun.co.uk |
| Cook Medical | View profile | 10001+ | Bloomington, Indiana, United States, North America | www.cookmedical.com |
| Biosensors | View profile | 1001-5000 | Singapore, Central Region, Singapore, Asia | biosensors.com |
U.S. Interventional Cardiology Devices Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Interventional Cardiology Devices Market Outlook will help companies and investors design strategic landscapes.
Coronary Stents was the largest segment with a revenue share of 51.25% in 2025.
Horizon Databook has segmented the U.S. interventional cardiology devices market based on coronary stents, ptca balloon catheters, intravascular imaging catheters and pressure guidewires, accessory devices covering the revenue growth of each sub-segment from 2021 to 2033.
In the U.S., heart diseases and stroke pose a significant health burden, affecting approximately 795,000 individuals annually. The frequency is overwhelming, with individuals experiencing a stroke every 40 seconds, and every 4 minutes, a person dies due to stroke, totaling more than 140,000 deaths each year.
In another development, in February 2022, Boston Scientific Corporation announced the acquisition of Baylis Medical Company Inc., a company that offers sheaths, dilators, guidewires, and advanced transseptal access solutions used to support left heart catheter-based procedures.
Reimbursement scenarios and costs for cardiology devices in the U.S. are primarily determined by various public and private payers, including Medicare, Medicaid, & private insurance companies. A few manufacturers also provide guides for payment, such as Boston Scientific, which annually publishes clear instructions on procedural billing & reimbursement payer policies for inpatient, outpatient, office, and ASC settings.
- U.S. Interventional Cardiology Devices Market Products Outlook (Revenue, USD Million , 2021-2033)
- Coronary Stents
- PTCA Balloon Catheters
- Intravascular Imaging Catheters and Pressure Guidewires
- Accessory Devices
- U.S. Interventional Cardiology Devices Market Procedures Outlook (Revenue, USD Million , 2021-2033)
- Coronary Artery Disease (CAD)
- Acute Myocardial Infarction (AMI)
- Chronic Total Occlusion (CTO)
- U.S. Interventional Cardiology Devices Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Cath Labs
- Ambulatory Surgical Centers (ASCs)
- Specialty Cardiac Centers
Reasons to subscribe to Interventional Cardiology Devices Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Interventional Cardiology Devices Market Outlook databook
- Our clientele includes a mix of Interventional Cardiology Devices Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Interventional Cardiology Devices Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Interventional Cardiology Devices Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Interventional Cardiology Devices Market, 2021-2033 (US$M)
U.S. interventional cardiology devices market statistics, by products, 2021-2033 (US$M)
